Preablation Stimulated Thyroglobulin/TSH Ratio As a Predictor of Successful I131remnant Ablation in Patients with Differentiated Thyroid Cancer Following Total Thyroidectomy

被引：0
|
作者：
Hussain, Syed Zubair [1 ]
Zaman, Maseeh Uz [1 ]
Malik, Sarwar [1 ]
Ram, Nanik [1 ]
Asghar, Ali [1 ]
Rabbani, Unaib [1 ]
Aftab, Nida [2 ]
Islam, Najmul [1 ]
机构：
[1] Aga Khan Univ Hosp, Karachi, Pakistan
[2] Dow Med Coll, Karachi, Pakistan
来源：
ENDOCRINE REVIEWS | 2014年 / 35卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SUN-0579
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Early preablation rhTSH-stimulated thyroglobulin predicts outcome of differentiated thyroid cancer (DTC) patients
    Alfredo Campennì
    Rosaria Maddalena Ruggeri
    Massimiliano Siracusa
    Alessio Danilo Comis
    Davide Romano
    Antonio Vento
    Helena Lanzafame
    Francesca Capoccetti
    Angela Alibrandi
    Sergio Baldari
    Luca Giovanella
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 2466 - 2475
  • [32] Early preablation rhTSH-stimulated thyroglobulin predicts outcome of differentiated thyroid cancer (DTC) patients
    Campenni, Alfredo
    Ruggeri, Rosaria Maddalena
    Siracusa, Massimiliano
    Comis, Alessio Danilo
    Romano, Davide
    Vento, Antonio
    Lanzafame, Helena
    Capoccetti, Francesca
    Alibrandi, Angela
    Baldari, Sergio
    Giovanella, Luca
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (08) : 2466 - 2475
  • [33] Recombinant TSH or thyroid hormone withdrawal?: A comparison of I-131 remnant ablation rates in thyroid cancer patients
    Luster, M
    Ladenson, P
    Pacini, F
    Schlumberger, M
    Driedger, A
    Kloos, R
    Sherman, S
    Corone, C
    Haugen, B
    Lassmann, M
    Hänscheid, H
    Reiners, C
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S290 - S291
  • [34] Ablation of thyroid remnant with 30 mCi 131I in thyroid cancer patients prepared with recombinant human TSH
    Rosario, Pedro Weslley
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2012, 56 (05) : 338 - 340
  • [35] Outcome of different activity of 131I for first remnant ablation in the patients with differentiated thyroid cancer
    Chen, Yonghui
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [36] Review:: 131I activity for remnant ablation in patients with differentiated thyroid cancer:: A systematic review
    Hackshaw, Allan
    Harmer, Clive
    Mallick, Ujjal
    Haq, Masud
    Franklyn, Jayne A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (01): : 28 - 38
  • [37] I-131 for Remnant Ablation in Differentiated Thyroid Cancer After Thyroidectomy: A Meta-Analysis of Randomized Controlled Evidence
    Yan Shengguang
    Ji-Eun, Choi
    He Lijuan
    MEDICAL SCIENCE MONITOR, 2016, 22 : 2439 - 2450
  • [38] EMPIRIC 131I TREATMENT OF HIGH THYROGLOBULIN LEVELS IN DIFFERENTIATED THYROID CARCINOMA AFTER REMNANT ABLATION
    Kalender, Ebuzer
    Elboga, Umut
    Celen, Y. Zeke
    Demir, H. Deniz
    Sahin, Ertan
    Karacavus, Seyhan
    ACTA MEDICA MEDITERRANEA, 2014, 30 (02): : 503 - 507
  • [39] Stimulating thyroglobulin to TSH ratio predict long-term efficacy of 131I therapy in patients with differentiated thyroid cancer after total thyroidectomy: a retrospective study (Vol 84, pg 1064, 2024)
    Yin, Xue
    Lu, Chao
    Sun, Danyang
    Ji, Yanhui
    Wang, Yan
    Zheng, Hongyuan
    Ma, Ziyu
    Jia, Qiang
    Tan, Jian
    Zheng, Wei
    ENDOCRINE, 2024, 86 (02) : 863 - 863
  • [40] I-131 remnant ablation after thyroidectomy induced hepatotoxicity in a case of thyroid cancer
    Lin, Rong
    Banafea, Omar
    Ye, Jin
    BMC GASTROENTEROLOGY, 2015, 15
12345